...
【24h】

Improvement of generalised dystonia by olanzapine treatment.

机译:奥氮平治疗可改善广泛性肌张力障碍。

获取原文
获取原文并翻译 | 示例
           

摘要

This is the first report on generalised dystonia beneficially treated by olanzapine. A 63-year-old Taiwanese man with intractable general dystonia was treated with olanzapine starting at a dose of 2.5 mg/day to the maximal dose of 15 mg/day. Clinically, there was slow, but steady, improvement in his dystonia and disability after olanzapine treatment. Evaluation of his dystonia 3 months later revealed 70% improvement on dystonic movement and 60% on disability on the Burke-Fahn-Marsden Dystonia Scale. The result suggests that treatment with olanzapine can be an alternative therapy for patients with generalised dystonia.
机译:这是奥氮平有益治疗的广泛性肌张力障碍的首次报道。一名63岁的患有顽固性一般性肌张力障碍的台湾男子接受奥氮平治疗,剂量从2.5毫克/天开始,到最大剂量15毫克/天。临床上,奥氮平治疗后的肌张力障碍和残疾有缓慢但稳定的改善。 3个月后评估他的肌张力障碍,发现Burke-Fahn-Marsden肌张力障碍量表的肌张力障碍运动改善了70%,残疾改善了60%。结果表明,对于广泛性肌张力障碍患者,奥氮平治疗可能是另一种治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号